October 15, 2009 - Kemeta, LLC and Kronos Science Laboratories announce their collaborative agreement to study fat metabolism through a series of human clinical studies. Kemeta is commercializing a patented palm-size breath analyzer that specifically and immediately detects if, and at what rate, the user is burning fat....
...The Kemeta product will have application in the prevention of weight related diseases such as type 2 diabetes, hypertension and cardiovascular disease as well as the optimization of personal health and fitness programs. The U.S. Center for Disease Control studies show that people with pre-diabetes can prevent or delay full blown type 2 diabetes by losing at least 7% of their body weight and engaging in moderate physical activity at least 150 minutes per week... Kemeta's Press Release -
